<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>Safety on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><link>https://glp1decode.com/zh/tags/safety/</link><description>Recent content in Safety on GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</description><image><title>GLP-1 指南 — Ozempic、Wegovy、Mounjaro 循证解读</title><url>https://glp1decode.com/images/default-og.png</url><link>https://glp1decode.com/images/default-og.png</link></image><generator>Hugo</generator><language>zh</language><lastBuildDate>Tue, 16 Jun 2026 00:00:00 +0000</lastBuildDate><atom:link href="https://glp1decode.com/zh/tags/safety/index.xml" rel="self" type="application/rss+xml"/><item><title>复方司美格鲁肽 vs 品牌药 Ozempic：安全性、成本与风险（2026）</title><link>https://glp1decode.com/zh/posts/compounded-semaglutide-vs-brand-2026/</link><pubDate>Tue, 16 Jun 2026 00:00:00 +0000</pubDate><guid>https://glp1decode.com/zh/posts/compounded-semaglutide-vs-brand-2026/</guid><description>复方司美格鲁肽安全吗？比较复方药与品牌药 Ozempic 和 Wegovy——FDA 警告、质量风险、成本差异，以及 2026 年从调配药房购买时需要注意的事项。</description></item></channel></rss>